Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Common Name
Baiyunshan Pharmaceutical Holdings
Country
China (Mainland)
Sector
Healthcare
Industry
Medical Distribution
Employees
28,138
Ticker
600332
Exchange
SHANGHAI STOCK EXCHANGE
Description
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. is a prominent Chinese pharmaceutical manufacturer renowned for its comprehensive range of health products. The company's primary function is the ...

Baiyunshan Pharmaceutical Holdings Waste Data Preview

In 2023, Baiyunshan Pharmaceutical Holdings conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into Baiyunshan Pharmaceutical Holdings’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Baiyunshan Pharmaceutical Holdings generated a total of 50,651 metric tonnes of waste.

Of this amount, 2.15% of Baiyunshan Pharmaceutical Holdings's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 97.85% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

Baiyunshan Pharmaceutical Holdings’s Hazardous vs Non-Hazardous Waste Over Time

202120222023015 k30 k45 k60 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How Baiyunshan Pharmaceutical Holdings reduced the environmental impact of its waste?

Since 2021, Baiyunshan Pharmaceutical Holdings's total waste generation increased by 98.23%, including a 35.28% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.

Over the same period, Baiyunshan Pharmaceutical Holdings reduced the hazardousness of its waste by 11.33%, with a further 8.9% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.

Overall, Baiyunshan Pharmaceutical Holdings is generating more waste but has significantly reduced the share of hazardous materials, suggesting a partial decoupling of volume and toxicity that could reflect more responsible inputs or enhanced treatment.

Want Full Access to Baiyunshan Pharmaceutical Holdings's Waste Management Dataset?
Sign Up